You are here: Industry Insights > SARS-CoV-2

News List

Third COVID-19 vaccine dose could improve protection in transplant recipients europeanpharmaceuticalreview
August 13, 2021
The results from the first COVID-19 vaccine booster trial in transplant recipients show a third dose is safe and highly immunogenic.
DiaCarta Receives CE/IVD for its New COVID 19 test that Identifies Delta Plus and New Variants prnewswire
August 13, 2021
DiaCarta Inc., today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can now be commercialized within the EU and rest of the world.
Pfizer Shot May Help Fight COVID Variants in People Previously Infected drugs
August 12, 2021
A small, early study suggests that people who've already encountered SARS-CoV-2 may gain a big boost against COVID-19 if they get just one dose of the Pfizer vaccine — and that protection may extend to new viral variants.
New At-Home Finger Prick Test Helps People Understand How They're Responding To SARS-CoV-2 Vaccine In 24-48 Hours prnewswire
August 12, 2021
Epitome Risk's new at-home finger prick test method lets people know how well they responded to their COVID vaccine within 24-48 hours.
COVID-19, patient needs and sustainability driving drug delivery tech innovation cphi-online
August 11, 2021
Innovation is the cornerstone of the drug delivery technology sector; efforts to make therapies more convenient for patients, reduce side effects and differentiate products from the competition have always made the delivery sector a hotbed of new ideas.
Antibodies to SARS-CoV-2 remain stable, or even increase, seven months after infection worldpharmanews
August 10, 2021
The levels of IgG antibodies against SARS-CoV-2 Spike protein remain stable, or even increase, seven months after infection, according to a follow-up study in a cohort of healthcare workers coordinated by the Barcelona Institute for Global Health ...
SARS-CoV-2 Reinfection More Likely in Unvaccinated Individuals drugs
August 10, 2021
Among Kentucky residents who were infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020, those who were unvaccinated against COVID-19 had an increased likelihood of reinfection in May to June 2021.
India authorises J&J’s Covid-19 vaccine for emergency use pharmaceutical-technology
August 09, 2021
India has approved Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine for emergency use, expanding the total number of anti-SARS-CoV-2 vaccines authorised in the country to five.
BD and CerTest Biotec Announce CE Mark for Molecular Test to Detect, Identify Certain SARS-CoV-2 Variants b3cnewswire
August 09, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the CE mark for a molecular test that can detect and distinguish between the Alpha (B.1.1.7), Beta (B.1.351) and Gamma (P.1) SARS-CoV-2 variants.
REGEN-COV Authorized for Postexposure Prophylaxis in High-Risk Individuals August 05, 2021
The monoclonal antibody therapy REGEN-COV was authorized for emergency use as a postexposure prophylaxis for COVID-19 in those at high risk for severe disease, the U.S. Food and Drug Administration announced Friday.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page